Pfizer Inc. stock falls Thursday, still outperforms market


Shares of Pfizer Inc.
PFE,

sank 0.30% to $36.75 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index
SPX,

falling 0.38% to 3,795.54 and Dow Jones Industrial Average
DJIA,

falling 0.22% to 30,991.52. This was the stock’s third consecutive day of losses. Pfizer Inc. closed $6.33 short of its 52-week high ($43.08), which the company reached on December 9th.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson
JNJ,

rose 1.75% to $160.65, Merck & Co. Inc.
MRK,

fell 0.21% to $82.17, and Novartis AG ADR
NVS,

rose 1.40% to $94.62. Trading volume (30.2 M) remained 20.1 million below its 50-day average volume of 50.3 M.


Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.



Read More: Pfizer Inc. stock falls Thursday, still outperforms market

article_normalC&E Exclusion FilterC&E Industry News FiltercommodityCommodity/Financial Market NewsContent TypescorporateCorporate/Industrial NewsdisruptionsEquity MarketsFactiva Filtersfallsfinancial market newsFinancial Performancehealth careHealth Care/Life Sciencesindustrial newslife sciencesmarketoutperformsPfizerPharmaceuticalsshare price movementShare Price Movement/DisruptionsstockThursday
Comments (0)
Add Comment